SCHEMBL24258026

SCHEMBL24258026

Cc1cccc2c(Cc3nc(-c4ccc(Cl)nc4)no3)cccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.43
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
MAPT P10636 3/20 0.43
TSHR P16473 7/20 0.43
MAPK1 P28482 6/20 0.43
TDP1 Q9NUW8 5/20 0.43
PTPN1 P18031 5/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.42
CASP3 P42574 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258028 0.87 CASP3 (0.43) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL26004980 0.77 TSHR (0.48) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL24258043 0.76 S1PR1 (0.59) SMN1; SMN2RAB9ANPC1TSHRMAPK1
SCHEMBL24258005 0.75 CYP1A2 (0.51) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL24258045 0.74 CYP1A2 (0.66) SMN1; SMN2RAB9ANPC1TSHRMAPK1
SCHEMBL24258025 0.72 CYP1A2 (0.53) SMN1; SMN2RAB9ANPC1TSHRMAPK1
SCHEMBL24258078 0.71 CYP1A2 (0.50) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL24258075 0.71 ERCC1 (0.52) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL25336449 0.71 CASP3 (0.55) SMN1; SMN2RAB9ANPC1MAPTTSHR
SCHEMBL2567937 0.67 HDAC6 (0.54) SMN1; SMN2RAB9ANPC1MAPTCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035805-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed